Signal Genetics, Inc. (SGNL) - Product Pipeline Analysis, 2016 Update

Report code: GDME279932PD

Publisher: GlobalData

Formats: PDF

Published: July 05, 2016

Number of pages: 25

Signal Genetics, Inc. (Signal Genetics) is a molecular diagnostic company that offers diagnostic services. The company's Myeloma Prognostic Risk Signature test is a microarray-based gene expression profiling assay used to assist the management of patients with multiple myeloma and related disorders. It offers biopharma services such as Signal Genetics collaborative research capabilities, specimen processing, gene expression profiling, online result reporting, and regulatory and data management expertise. Signal Genetics provides the MyPRS test, CLIA-certified reference laboratory located in Little Rock, Arizona. The company's research laboratory performs cell-sorting, isolation and gene expression profiling services for pharmaceutical and research organizations. Signal Genetics is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Signal Genetics, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Signal Genetics, Inc. Company Snapshot 5

Signal Genetics, Inc. Company Overview 5

Signal Genetics, Inc. Pipeline Products and Clinical Trials Overview 6

Signal Genetics, Inc. – Pipeline Analysis Overview 8

Key Facts 8

Signal Genetics, Inc. - Major Products and Services 9

Signal Genetics, Inc. Pipeline Products by Development Stage 10

Signal Genetics, Inc. Pipeline Products Overview 11

BreastGeneDX 11

BreastGeneDX Product Overview 11

ColonGeneDX 12

ColonGeneDX Product Overview 12

LungGeneDX 13

LungGeneDX Product Overview 13

Signal Genetics, Inc. - Key Competitors 14

Signal Genetics, Inc. - Key Employees 15

Signal Genetics, Inc. - Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Signal Genetics, Inc., Recent Developments 17

May 26, 2016: Signal Genetics Receives Extension to Comply with Nasdaq Continued Listing Requirement 17

May 16, 2016: Signal Genetics Highlights Recent Achievements And Reports First Quarter 2016 Financial Results 17

Mar 16, 2016: Signal Genetics Highlights Recent Achievements and Reports Fourth Quarter and Full-Year 2015 Financial Results 18

Nov 12, 2015: Signal Genetics Highlights Recent Achievements and Reports Third Quarter 2015 Financial Results 19

Nov 05, 2015: Signal Genetics' MyPRS Highlighted in the Journal Leukemia 21

Oct 20, 2015: Signal Genetics Expands Reimbursement of MyPRS With Additional Preferred Provider Organization Agreements 21

Sep 24, 2015: Signal Genetics Granted First European Patent for MyPRS 22

Sep 17, 2015: Signal Genetics Appoints Richard Bender, MD, FACP as Chief Medical Officer 22

Sep 08, 2015: Signal Genetics and Moffitt Cancer Center Enter Into Sponsored Research Agreement in Multiple Myeloma 22

Aug 12, 2015: Signal Genetics Highlights Recent Achievements and Reports Second Quarter 2015 Financial Results 23

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Tables

List of Tables

Signal Genetics, Inc. Pipeline Products and Clinical Trials Overview 6

Signal Genetics, Inc. Pipeline Products by Equipment Type 6

Signal Genetics, Inc. Pipeline Products by Indication 7

Signal Genetics, Inc., Key Facts 8

Signal Genetics, Inc., Major Products and Services 9

Signal Genetics, Inc. Number of Pipeline Products by Development Stage 10

Signal Genetics, Inc. Pipeline Products Summary by Development Stage 10

BreastGeneDX - Product Status 11

BreastGeneDX - Product Description 11

ColonGeneDX - Product Status 12

ColonGeneDX - Product Description 12

LungGeneDX - Product Status 13

LungGeneDX - Product Description 13

Signal Genetics, Inc., Key Employees 15

Signal Genetics, Inc., Other Locations 16

List of Figures

List of Figures

Signal Genetics, Inc. Pipeline Products by Equipment Type 7

Signal Genetics, Inc. Pipeline Products by Development Stage 10

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP